Upneeq
Eye Drops
A revolutionary FDA-approved treatment for acquired droopy eyelids — no surgery required.
About Upneeq
What Is Upneeq?
Upneeq (oxymetazoline hydrochloride ophthalmic solution, 0.1%) is the first and only FDA-approved prescription eye drop for acquired ptosis — the medical term for low-lying eyelids (droopy eyelids). It offers a non-surgical solution that can lift the upper eyelid and open the eye for a more alert, refreshed appearance.
Non-Surgical
Lifts droopy eyelids without the need for invasive surgery or recovery time.
FDA-Approved
The first and only prescription eye drop specifically approved for acquired ptosis.
Once Daily Use
Applied once per day, one drop in each affected eye, for convenient daily treatment.
Clinically Proven
Demonstrated effectiveness in lifting the upper eyelid by 1mm or more in clinical studies.
What Is Acquired Ptosis?
Acquired ptosis is a condition where the upper eyelid droops lower than normal, partially covering the eye. Unlike congenital ptosis (present from birth), acquired ptosis develops over time — often due to aging, contact lens wear, eye surgery, or muscle or nerve issues. It can make you look tired or older and may even interfere with vision in severe cases.